Form D · Biotechnology
Exa Biosciences, Inc.
Boston, MA · CIK 0002033324
Offering snapshot reported Aug 14, 2024 · SEC filing
- Reported sold
- $50K Offering amount: $400K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jul 31, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 14, 2024 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-521473
Source: Form D, filed Aug 14, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Xun Chen | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
867 Boylston Street 5 Th Floor 1827
Boston, MA, 02116
Boston, MA, 02116